Tarsus Pharmaceuticals (TARS) Earnings Analysis
Tarsus Pharmaceuticals (TARS) next reports earnings on 2026-08-06, consensus EPS -0.21 USD. Last quarter (2026-02-23) it missed with EPS -0.2 USD vs -0.103 USD est (-94.2%). It has beaten estimates in 1/2 recent quarters (50%). Trailing P/E -50.51.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does TARS next report earnings?
| Next earnings date | 2026-08-06 |
|---|---|
| Consensus EPS estimate | -0.21 USD |
| Revenue estimate | 0.17B |
TARS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-02-23 | -0.2 USD | -0.103 USD | -94.2% | Miss |
| 2025-05-01 | -0.64 USD | -0.69 USD | +7.2% | Beat |
Beat rate: 1/2 (50%) over reported quarters with consensus data.
TARS valuation and analyst view
| Trailing P/E | -50.51 |
|---|---|
| Trailing EPS | -1.12357 USD |
| Price / book | 7.09 |
| Dividend yield | 0.00% |
| Market cap | 2.48B |
| Analyst consensus | Buy (8 buy / 1 hold / 0 sell) |
| Avg price target | 89 USD |
Related research pages
Frequently asked questions
When is Tarsus Pharmaceuticals (TARS)'s next earnings date?
Tarsus Pharmaceuticals is next scheduled to report on 2026-08-06, with a consensus EPS estimate of -0.21 USD and revenue estimate of 0.17B.
Did TARS beat earnings last quarter?
In its 2026-02-23 report, TARS posted EPS of -0.2 USD versus a -0.103 USD estimate — a miss of 94.2%.
What is TARS's earnings track record?
Over the last 2 reported quarters with consensus data, TARS beat estimates 1 times (50%).
What is TARS's current P/E ratio and EPS?
TARS trades at a trailing P/E of -50.51 on trailing EPS of -1.1235661320922217 USD.
What do analysts rate TARS?
Analyst consensus is "Buy" across 9 ratings (1 strong buy, 7 buy, 1 hold, 0 sell, 0 strong sell). Average 12-month price target: 89 USD.